Cargando…
Efficacy and Safety of Leflunomide for Refractory COVID-19: A Pilot Study
Background: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may persist in patients with coronavirus disease 2019 (COVID-19) despite receiving standard care. Methods: In this pilot study of hospitalized adult patients (≥18 years of age), with radiologically confirmed pneumonia who w...
Autores principales: | Wang, Qiang, Guo, Haipeng, Li, Yu, Jian, Xiangdong, Hou, Xinguo, Zhong, Ning, Fei, Jianchun, Su, Dezhen, Bian, Zhouyan, Zhang, Yi, Hu, Yingying, Sun, Yan, Yu, Xueyuan, Li, Yuan, Jiang, Bei, Li, Yan, Qin, Fengping, Wu, Yingying, Gao, Yanxia, Hu, Zhao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284962/ https://www.ncbi.nlm.nih.gov/pubmed/34276351 http://dx.doi.org/10.3389/fphar.2021.581833 |
Ejemplares similares
-
Treatment of refractory lupus nephritis using leflunomide: A prospective study
por: Zhang, Shuo, et al.
Publicado: (2023) -
Leflunomide-induced pulmonary arterial hypertension in a young man with nephrotic syndrome: A case report
por: Luo, Xiaoqin, et al.
Publicado: (2022) -
The Role of Cold Inducible RNA-Binding Protein in Cardiac Physiology and Diseases
por: Zhong, Peng, et al.
Publicado: (2021) -
Leflunomide Induces Dose-Dependent Lung Injury in Mice via Stimulating Vimentin and NLRP3 Inflammasome Production
por: El-Sherbiny, Mohamed, et al.
Publicado: (2021) -
Cytokine Release Syndrome Is an Independent Risk Factor Associated With Platelet Transfusion Refractoriness After CAR-T Therapy for Relapsed/Refractory Acute Lymphoblastic Leukemia
por: Liu, Yadan, et al.
Publicado: (2021)